Stock Research: Chong Kun Dang

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Chong Kun Dang

KSC:185750 KR7185750007
53
  • Value
    57
  • Growth
    12
  • Safety
    Safety
    80
  • Combined
    52
  • Sentiment
    86
  • 360° View
    360° View
    53
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Chong Kun Dang Pharmaceutical Corp manufactures and sells pharmaceuticals, including prescription and over-the-counter drugs, quasi-drugs, and health functional foods. The company operates in the pharmaceutical and healthcare industries, with products including antidiabetic treatments, cerebrovascular disease treatments, and OTC drugs like penzal. It sells products domestically and internationally. In the last fiscal year, the company had a market cap of $821 million, profits of $361 million, and revenue of $1074 million. The number of employees is not available.

more
Index
KOSPI
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
57 46 34 51
Growth
12 6 93 15
Safety
Safety
80 65 34 55
Sentiment
86 76 98 73
360° View
360° View
53 46 85 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
65 88 69 82
Opinions Change
50 26 64 50
Pro Holdings
n/a 64 80 10
Market Pulse
93 76 89 93
Sentiment
86 76 98 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
57 46 34 51
Growth
12 6 93 15
Safety Safety
80 65 34 55
Combined
52 49 50 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
88 84 70 87
Price vs. Earnings (P/E)
39 51 40 51
Price vs. Book (P/B)
50 43 29 39
Dividend Yield
50 34 31 32
Value
57 46 34 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
24 27 21 40
Profit Growth
15 11 89 16
Capital Growth
6 31 84 85
Stock Returns
53 26 93 5
Growth
12 6 93 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
48 43 31 40
Refinancing
63 80 53 71
Liquidity
90 57 45 47
Safety Safety
80 65 34 55

Similar Stocks

Discover high‑ranked alternatives to Chong Kun Dang and broaden your portfolio horizons.

Mitsubishi HC Capital

TYO:8593
Country: Japan
Industry: Specialized Finance
Size: X-Large
Full Stock Analysis

E1

KSC:017940
Country: South Korea
Industry: Oil & Gas Transportation
Size: Large
Full Stock Analysis

Hyundai Home Shopping Network

KSC:057050
Country: South Korea
Industry: Internet Retail
Size: Medium
Full Stock Analysis

Orion

KSC:001800
Country: South Korea
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: